0 0 Cornwall Medical Group Limited 13540921 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is specialist medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true true 13540921 2024-04-01 2025-03-31 13540921 2025-03-31 13540921 bus:OrdinaryShareClass1 2025-03-31 13540921 core:RetainedEarningsAccumulatedLosses 2025-03-31 13540921 core:ShareCapital 2025-03-31 13540921 core:CurrentFinancialInstruments 2025-03-31 13540921 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 13540921 core:OfficeEquipment 2025-03-31 13540921 bus:SmallEntities 2024-04-01 2025-03-31 13540921 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13540921 bus:FilletedAccounts 2024-04-01 2025-03-31 13540921 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13540921 bus:RegisteredOffice 2024-04-01 2025-03-31 13540921 bus:Director1 2024-04-01 2025-03-31 13540921 bus:Director2 2024-04-01 2025-03-31 13540921 bus:Director3 2024-04-01 2025-03-31 13540921 bus:Director4 2024-04-01 2025-03-31 13540921 bus:Director5 2024-04-01 2025-03-31 13540921 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 13540921 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13540921 core:OfficeEquipment 2024-04-01 2025-03-31 13540921 core:PlantMachinery 2024-04-01 2025-03-31 13540921 1 2024-04-01 2025-03-31 13540921 countries:England 2024-04-01 2025-03-31 13540921 2024-03-31 13540921 core:OfficeEquipment 2024-03-31 13540921 2023-04-01 2024-03-31 13540921 2024-03-31 13540921 bus:OrdinaryShareClass1 2024-03-31 13540921 core:RetainedEarningsAccumulatedLosses 2024-03-31 13540921 core:ShareCapital 2024-03-31 13540921 core:CurrentFinancialInstruments 2024-03-31 13540921 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 13540921 core:OfficeEquipment 2024-03-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 13540921

Cornwall Medical Group Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

Cornwall Medical Group Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Cornwall Medical Group Limited

Company Information

Directors

Dr G Lin Sin Cho

Dr R Murthy

Dr K Smithson

Dr G E Moon

Mr J S Casey

Registered office

The Surgery
Tregony Road
Probus
Cornwall
TR2 4JZ

 

Cornwall Medical Group Limited

(Registration number: 13540921)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

1,200

1,775

Current assets

 

Stocks

5

477

477

Debtors

6

1,510

1,247

Cash at bank and in hand

 

118,267

125,227

 

120,254

126,951

Creditors: Amounts falling due within one year

7

(166,206)

(151,611)

Net current liabilities

 

(45,952)

(24,660)

Total assets less current liabilities

 

(44,752)

(22,885)

Provisions for liabilities

(300)

(444)

Net liabilities

 

(45,052)

(23,329)

Capital and reserves

 

Called up share capital

8

100

100

Retained earnings

(45,152)

(23,429)

Shareholders' deficit

 

(45,052)

(23,329)

 

Cornwall Medical Group Limited

(Registration number: 13540921)
Balance Sheet as at 31 March 2025

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 2 August 2025 and signed on its behalf by:
 

.........................................
Dr R Murthy
Director

 

Cornwall Medical Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
The Surgery
Tregony Road
Probus
Cornwall
TR2 4JZ

These financial statements were authorised for issue by the Board on 2 August 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Disclosure of long or short period

The comparatives are for the 9 month period from 1 July 2023 to 31 March 2024.

 

Cornwall Medical Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Going concern

The directors acknowledge the company's result for the year and the balance sheet position - which reflects that the company has both net current liabilities and net liabilities at the year end date.

Included within creditors: amounts due within one year is £163,173 owed to the parent company: Probus Surgery Limited. This was loaned to the company to support start up costs and to support ongoing trading, needed due to the infantile stage of this company. The parent company has provided assurance that this debt will not be called until the company is in a position to afford the repayment.

On the basis of these assurances, the directors have satisfied themselves that the company is a going concern and have prepared the accounts on this basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Cornwall Medical Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and equipment

33% reducing balance

Stocks

Stocks are stated at the lower of cost and estimated selling price.

At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2024 - 0).

 

Cornwall Medical Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4

Tangible assets

Furniture, fittings and equipment
£

Total
£

Cost or valuation

At 1 April 2024

3,086

3,086

At 31 March 2025

3,086

3,086

Depreciation

At 1 April 2024

1,311

1,311

Charge for the year

575

575

At 31 March 2025

1,886

1,886

Carrying amount

At 31 March 2025

1,200

1,200

At 31 March 2024

1,775

1,775

5

Stocks

2025
£

2024
£

Other inventories

477

477

6

Debtors

Current

2025
£

2024
£

Prepayments

1,110

1,247

Other debtors

400

-

 

1,510

1,247

 

Cornwall Medical Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

7

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Trade creditors

 

-

13,439

Amounts owed to group undertakings and undertakings in which the company has a participating interest

9

163,173

135,772

Accruals and deferred income

 

2,400

2,400

Other creditors

 

633

-

 

166,206

151,611

8

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

       

9

Related party transactions

The company's immediate parent company is Probus Surgery Limited, incorporated in England and Wales.